Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ATPases as drug targets: learning from their structure.

Patrick Chène1

  • 1Oncology Department, Novartis, K125 442, CH-4002 Basel, Switzerland. patrick_chene@yahoo.com

Nature Reviews. Drug Discovery
|September 5, 2002
PubMed
Summary

Adenosine Triphosphatases (ATPases) are crucial for cell function and disease, making them key drug targets. This review explores designing competitive ATP inhibitors by analyzing ATPase nucleotide-binding site structures for novel drug discovery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery of Clinical Candidate IAG933, a Potent YAP-TEAD PPI Disrupter.

Journal of medicinal chemistry·2026
Same author

Study of the TEAD-binding domain of the VGLL1, VGLL2 and VGLL3 proteins from vertebrates.

Archives of biochemistry and biophysics·2024
Same author

Author Correction: Direct and selective pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits Hippo-dependent and RAS-MAPK-altered cancers.

Nature cancer·2024
Same author

Direct Inhibition of the YAP : TEAD Interaction: An Unprecedented Drug Discovery Challenge.

ChemMedChem·2024
Same author

mRNA Display Identifies Potent, Paralog-Selective Peptidic Ligands for ARID1B.

ACS chemical biology·2024
Same author

Direct and selective pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits Hippo-dependent and RAS-MAPK-altered cancers.

Nature cancer·2024

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • ATPases play vital roles in cellular processes.
  • Dysfunctional ATPases are implicated in numerous human diseases.
  • Existing ATPase inhibitors often lack direct nucleotide-binding site interaction.

Purpose of the Study:

  • To review the structural characteristics of ATPase nucleotide-binding sites.
  • To analyze how structural insights can guide the development of competitive ATP inhibitors.
  • To explore a novel drug discovery strategy targeting ATPases.

Main Methods:

  • Literature review of ATPase structures.
  • Analysis of nucleotide-binding site features across different ATPases.
  • Comparative study of inhibitor design strategies.

Main Results:

  • Detailed description of diverse ATPase nucleotide-binding site architectures.
  • Identification of conserved and variable structural elements.
  • Assessment of the feasibility of exploiting structural data for inhibitor design.

Conclusions:

  • Understanding ATPase nucleotide-binding site structure is critical for developing effective competitive ATP inhibitors.
  • This approach offers a promising alternative to existing inhibition strategies.
  • Structural information can be leveraged for targeted drug discovery against various ATPases.

Related Experiment Videos